Shengzhong Hou
State Key Laboratory Of Biotherapy
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MALAT1 promotes epithelial-mesenchymal transition of pancreatic cancer cells through the miR-141-5p-TGF-ß-TGFBR1/TGFBR2 axis.
Journal: European cytokine network
Published: January 09, 2025
Targeting lipid metabolism via nanomedicine: A prospective strategy for cancer therapy.
Journal: Biomaterials
Published: September 09, 2024
Perioperative outcomes and long-term survival of cryosurgery on unresectable pancreatic cancer: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: December 15, 2023
Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.
Journal: Journal of clinical medicine
Published: August 10, 2022
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
Journal: International journal of oncology
Published: August 03, 2021
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma: A Meta-analysis.
Journal: Pancreas
Published: August 13, 2019
Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG).
Journal: Journal of thrombosis and thrombolysis
Published: June 29, 2019
Last Updated: 09/26/2026